|
J. Biol. Chem., Vol. 261, Issue 19, 8624-8632, 07, 1986
Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons
SR Brandwein
The effects of prostaglandin E2 (PGE2), cyclic nucleotides, leukotriene B4
(LTB4), and interferons on interleukin 1 (IL 1) production by
lipopolysaccharide (LPS)-stimulated C3H/HeNCrl mouse peritoneal macrophages
were studied. IL 1 production was inhibited by PGE2, the adenosine
3':5'-monophosphate analog dibutyryl cAMP, the cAMP agonist isoproterenol,
and the phosphodiesterase inhibitor isobutylmethylxanthine. These agents
were more inhibitory when added early in the latent phase of IL 1 synthesis
following stimulation with LPS rather than just prior to release of IL 1
into the medium. Production of both the intracellular and extracellular
forms of IL 1 was blocked by PGE2 and cAMP. Suppression of LPS-induced IL 1
production by PGE2 was prevented by leukocyte alpha-interferon. Moreover,
alpha-interferon augmented LPS-induced IL 1 production but did not
stimulate IL 1 production in the absence of LPS. Immune gamma- interferon
markedly inhibited LPS-stimulated IL 1 production. The lipoxygenase
inhibitor eicosa-5,8,11,14-tetraynoic acid suppressed, whereas
3-amino-1-(3-trifluoromethylphenyl)-2-pyrazoline augmented, LPS- induced IL
1 production. The opposing effects of these agents suggested that
lipoxygenase metabolites do not act as inducers of IL 1 production.
Purified LTB4 did not stimulate base-line or augment LPS- induced IL 1
production (both intracellular and extracellular forms). Moreover, calcium
ionophore A23187 (a lipoxygenase activator) did not stimulate IL 1
production, alone or in combination with LTB4. Thus, net IL 1 production by
macrophages may be regulated by a balance between the effects of PGE2,
cAMP, alpha-interferon, and gamma-interferon, but not LTB4.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. J. Xu, J. S. Reichner, B. Mastrofrancesco, W. L. Henry Jr., and J. E. Albina
Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-{beta} Production
J. Immunol.,
February 15, 2008;
180(4):
2125 - 2131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, W. Bin, M.O. Aksoy, and S.G. Kelsen
Regulation of interleukin-1{beta} and interleukin-1{beta} inhibitor release by human airway epithelial cells
Eur. Respir. J.,
September 1, 2004;
24(3):
360 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev,
October 1, 2003;
83(4):
1069 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Perez, J. D. Ritzenthaler, and J. Roman
Transcriptional Regulation of the Interleukin-1beta Promoter via Fibrinogen Engagement of the CD18 Integrin Receptor
Am. J. Respir. Cell Mol. Biol.,
May 1, 1999;
20(5):
1059 - 1066.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Yoshikawa, A. Suzumura, T. Tamaru, T. Takayanagi, and M. Sawada
Effects of phosphodiesterase inhibitors on cytokine production by microglia
Multiple Sclerosis,
April 1, 1999;
5(2):
126 - 133.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Williams and E. Shacter
Regulation of Macrophage Cytokine Production by Prostaglandin E2. DISTINCT ROLES OF CYCLOOXYGENASE-1 AND -2
J. Biol. Chem.,
October 10, 1997;
272(41):
25693 - 25699.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|